Investigation on the immune reactions against complex antigens including gangliosides in the neuroimmunological diseases

神经免疫疾病中神经节苷脂等复杂抗原的免疫反应研究

基本信息

  • 批准号:
    16590854
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2005
  • 项目状态:
    已结题

项目摘要

Antiganglioside antibodies are frequently present in sera from patients with neuroimmunological diseases as Guillain Barre syndrome (GBS) and Miller Fisher syndrome (MFS). Each ganglioside coexists with phospholipids and other gangliosides in the plasma membrane. We investigated antibody reactivities against complex antigens composed of a ganglioside and a phospholipid or those composed of two species of gangliosides. Anti-GM1 IgG antibodies in GBS had stronger binding activities against a mixture of GM1 and such phospholipids as phosphatidic acid than against GM1 alone. However, such increase was not observed in anti-GQ1b IgG antibodies in MFS. This may be due to the difference in the amount of the negatively-charged sialic acid that each antigen has ; GM1 has one sialic acid whereas GQ1b has four sialic acids. Some GBS patients had the antibodies specific to the ganglioside complex, which is composed of two different gangliosides. Among them, the antibodies specific to GD1a-GD1b complex and/or GD1b-GT1b complex are associated with severe GBS requiring artificial ventilation. In addition, some MFS patients had the antibodies against ganglioside complexes that include GQ1b. For elucidating the pathogenetic roles of the antiganglioside antibodies in neuroimmunological diseases, we should pay attention on the antibody activities against those complex antigens. Investigating antibodies against the complex antigens also may be useful for diagnosis of neuroimmunological diseases as GBS and MFS.
抗神经节苷脂抗体经常存在于格林-巴利综合征(GBS)和米勒-费舍尔综合征(MFS)等神经免疫性疾病患者的血清中。每一种神经节苷脂与磷脂和其他神经节苷脂在质膜中共存。我们研究了抗体对由神经节苷脂和磷脂组成的复合抗原或由两种神经节苷脂组成的抗原的反应性。GBS抗GM1 IgG抗体对GM1与磷脂酸等磷脂混合物的结合活性比单独对GM1的结合活性强。然而,MFS中抗gq1b IgG抗体未观察到这种增加。这可能是由于每种抗原所含的带负电荷的唾液酸的数量不同;GM1有一个唾液酸,而GQ1b有四个唾液酸。一些GBS患者具有针对神经节苷脂复合物的抗体,该复合物由两种不同的神经节苷脂组成。其中,GD1a-GD1b复合物和/或GD1b-GT1b复合物特异性抗体与需要人工通气的严重GBS相关。此外,一些MFS患者具有抗神经节苷脂复合物的抗体,其中包括GQ1b。为了阐明抗神经节苷脂抗体在神经免疫性疾病中的发病作用,我们应该关注针对这些复杂抗原的抗体活性。研究针对复合抗原的抗体也可能对GBS和MFS等神经免疫学疾病的诊断有用。

项目成果

期刊论文数量(44)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Harmful effects of anti-GalNAc-GD1a antibodies and TNF-alpha on rat dorsal root ganglia.
抗 GalNAc-GD1a 抗体和 TNF-α 对大鼠背根神经节的有害影响。
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kamakura K;Kaida K;Kusunoki S;Miyamoto N;Masaki T;Nakamura R;Motoyoshi K;Fukuda J.
  • 通讯作者:
    Fukuda J.
Effects of phospholipids on antiganglioside antibody reactivity in GBS
  • DOI:
    10.1016/j.jneuroim.2004.09.018
  • 发表时间:
    2005-02-01
  • 期刊:
  • 影响因子:
    3.3
  • 作者:
    Hirakawa, M;Morita, D;Kusunoki, S
  • 通讯作者:
    Kusunoki, S
Anti-GQ1b antibody as a factor predictive of mechanical ventilation in Guillain-Barre syndrome
  • DOI:
    10.1212/01.wnl.0000113718.27729.43
  • 发表时间:
    2004-03-09
  • 期刊:
  • 影响因子:
    9.9
  • 作者:
    Kaida, K;Kusunoki, S;Kanazawa, I
  • 通讯作者:
    Kanazawa, I
Behcet disease presenting with neurological complications immediately after conversion from conventional cyclosporin A to microemulsion formulation.
从传统环孢菌素 A 转为微乳制剂后,白塞病立即出现神经系统并发症。
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Mitsui Y;Mitsui M;Urakami R;Kihara M;Takahashi M;Kusunoki S.
  • 通讯作者:
    Kusunoki S.
Autoantibodies in postinfectious acute cerebellar ataxia
  • DOI:
    10.1212/01.wnl.0000178802.38268.1e
  • 发表时间:
    2005-10-11
  • 期刊:
  • 影响因子:
    9.9
  • 作者:
    Uchibori, A;Sakuta, M;Chiba, A
  • 通讯作者:
    Chiba, A
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KUSUNOKI Susumu其他文献

KUSUNOKI Susumu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KUSUNOKI Susumu', 18)}}的其他基金

Investigation of the autoantibodies against complex antigens formed by two lipid molecules in neuroimmunological diseases
神经免疫疾病中两种脂质分子形成的复合抗原自身抗体的研究
  • 批准号:
    18H02745
  • 财政年份:
    2018
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of target antigens and pathogenetic mechanisms of neuroimmunological diseases using glycoarray
利用糖阵列分析神经免疫疾病的靶抗原和发病机制
  • 批准号:
    15H04845
  • 财政年份:
    2015
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of negative regulators of B lymphocyte responses to glycoconjugates in neuroimmunological diseases
神经免疫疾病中 B 淋巴细胞对糖复合物反应的负调节因子分析
  • 批准号:
    24390225
  • 财政年份:
    2012
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of the neuropathogenic mechanisms induced by the antiganglioside antibodies : the effect on signal transduction in neurons
抗神经节苷脂抗体诱发的神经病理机制分析:对神经元信号转导的影响
  • 批准号:
    21390273
  • 财政年份:
    2009
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of immunoreactivity against glycoproteins with disialosyl residue in neuroimmunological diseases
神经免疫疾病中二唾液酸残基糖蛋白的免疫反应性分析
  • 批准号:
    18390264
  • 财政年份:
    2006
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Investigation on the significance of the epitope formed by ganglioside and phospholipid in neuroimmunological diseases
神经节苷脂与磷脂形成的表位在神经免疫疾病中的意义研究
  • 批准号:
    14570581
  • 财政年份:
    2002
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of axonal degeneration by passive transfer of antiganglioside antibody and therapeutic trial for it.
抗神经节苷脂抗体被动转移引起的轴突变性及其治疗试验。
  • 批准号:
    12670595
  • 财政年份:
    2000
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of a ganglioside localized in paranodal region of peripheral nerve and induction of experimental autoimmune neuropathy
周围神经节旁区神经节苷脂的鉴定及实验性自身免疫性神经病的诱导
  • 批准号:
    10670576
  • 财政年份:
    1998
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigation on the pathogenetic mechanism of GD1b-induced experimental neuropathy and approach to effective treatment
GD1b引起的实验性神经病变的发病机制研究及有效治疗途径
  • 批准号:
    08670695
  • 财政年份:
    1996
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification and localization of minor glycolipid antigens recognized by serum antibody in Guillain-Barre' syndrome
格林-巴利综合征血清抗体识别的次要糖脂抗原的鉴定和定位
  • 批准号:
    05670551
  • 财政年份:
    1993
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

Ganglioside-CD44信号通路在PEMFs对小鼠缺血心肌血管生成影响中的作用及其机制研究
  • 批准号:
    81572231
  • 批准年份:
    2015
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目

相似海外基金

Nanoscopic Membrane Modulations Induced by Nanoscale Oligomers
纳米级低聚物诱导的纳米膜调节
  • 批准号:
    10790511
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Brain glycosphingolipids and Alzheimer's disease
脑鞘糖脂与阿尔茨海默病
  • 批准号:
    10738379
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Nanoscale assembly of amyloid oligomers at physiologically relevant conditions
淀粉样蛋白寡聚物在生理相关条件下的纳米级组装
  • 批准号:
    10733250
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Glycolipid biointerface to decipher disease-implicated ganglioside-protein interactions
糖脂生物界面破译疾病相关神经节苷脂-蛋白质相互作用
  • 批准号:
    10737003
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Immunotherapeutic targeting of gangliosides in Ewing Sarcoma
尤文肉瘤中神经节苷脂的免疫治疗靶向
  • 批准号:
    10715119
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Galectin-3 and engineered variants for clustering glycolipids and glycoproteinson membrane surfaces
Galectin-3 和用于在膜表面聚集糖脂和糖蛋白的工程变体
  • 批准号:
    10652941
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Dual antiretroviral loaded nanoparticles for long-acting suppressive HIV therapy
用于长效抑制艾滋病毒治疗的双重抗逆转录病毒纳米粒子
  • 批准号:
    10548482
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Improved Nanoparticle Targeting of Tissue Myeloid Cells for HIV-1 Long-acting Pre-exposure Prophylaxis
改进纳米颗粒对组织骨髓细胞的靶向,用于 HIV-1 长效暴露前预防
  • 批准号:
    10711555
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Title: Development and Validation of Therapy for GM1 Gangliosidosis
标题:GM1 神经节苷脂沉积症疗法的开发和验证
  • 批准号:
    10678309
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Oral Delivery of Therapeutic Peptides for Type II Diabetes and Obesity by Harnessing Endogenous Sphingolipid Trafficking
利用内源性鞘脂运输口服治疗 II 型糖尿病和肥胖症的肽
  • 批准号:
    10698654
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了